Related references
Note: Only part of the references are listed.Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors
P. Muhr et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Interleukin-22 Promotes Human Hepatocellular Carcinoma by Activation of STAT3
Runqiu Jiang et al.
HEPATOLOGY (2011)
Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis
Jian Guang Lu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
IL-1F5,-F6,-F8, and-F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression
Andrew Johnston et al.
JOURNAL OF IMMUNOLOGY (2011)
Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis
Yijun Carrier et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Interleukin-36-Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Slaheddine Marrakchi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interleukin-18: Biology and Role in the Immunotherapy of Cancer
S. Srivastava et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Activated Monocytes in Peritumoral Stroma of Hepatocellular Carcinoma Promote Expansion of Memory T Helper 17 Cells
Dong-Ming Kuang et al.
HEPATOLOGY (2010)
IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis
Hal Blumberg et al.
JOURNAL OF IMMUNOLOGY (2010)
Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways
Yi-Lan Zhang et al.
MOLECULAR CANCER (2010)
Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma
Peng Hu et al.
MOLECULAR IMMUNOLOGY (2009)
Survivin Expression Quantified by Image Pro-plus Compared With Visual Assessment
Chao-Jie Wang et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation
Hal Blumberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
The role of interleukin 1 in growth and metastasis of human cancer cenografts
DM Elaraj et al.
CLINICAL CANCER RESEARCH (2006)
Hepatocellular carcinoma: Epidemiology risk factors, and screening
M Sherman
SEMINARS IN LIVER DISEASE (2005)
Interleukin-2 gene expression is a new biological prognostic marker in hepatocellular carcinomas
M Ikeguchi et al.
ONKOLOGIE (2005)
Differential effects of IL-1α and IL-1β on tumorigenicity patterns and invasiveness
XP Song et al.
JOURNAL OF IMMUNOLOGY (2003)
Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity
WT Gao et al.
JOURNAL OF IMMUNOLOGY (2003)
Interleukin-1 - a major pleiotropic cyrtokine in tumor-host interactions
RN Apte et al.
SEMINARS IN CANCER BIOLOGY (2002)
Two novel IL-1 family members, IL-1δ and IL-1ε, function as an antagonist and agonist of NF-κB activation through the orphan IL-1 receptor-related protein 2
R Debets et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
